CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
Abstract
Summary
GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil",. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Brazil. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Brazil. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Brazil, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, GSK, Pfizer, Novartis and Hypera) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Roche, B Braun and Hologic)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Brazil
- Porter’s five forces analysis for pharmaceutical and medical devices market of Brazil
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Brazilian healthcare market.
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Italian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Brazilian healthcare market.
Content
Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Tables
Table 1: Top Five Therapeutic Areas based on Mortality by Major Disease Areas (thousand), Brazil, 2016
Table 2: Medical Device Market, Brazil, Revenue by Segment ($B), 2018
Table 3: General Surgery Devices Market, Brazil, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 4: Diagnostic Imaging Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2015
Table 5: IVD Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2017
Table 6:Ophthalmic Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2015
Table 7: Orthopedic Devices Market, Brazil, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 8: Patent Fees, Brazil, 2017
Table 9: Trademarks Fees ($), Brazil, 2014
List of Figures
Figure 1: Pharmaceutical Market, Brazil, Revenue ($B), 2015-2020
Figure 2: Medical Device Market, Brazil, Revenue ($B), 2015-2020
Figure 3: Number of Deals (2018-2019)
Figure 4: 2018-19 Deal Overview By Region
Figure 5: Country Profile, Brazil, 2018
Figure 6: Pharmaceutical Market, Brazil, Revenue ($B), 2010-2018
Figure 7: Pharmaceutical Market, Brazil, Revenue Forecast ($B), 2019-2022
Figure 8: Pharmaceutical Market, Brazil, Pharmaceutical Exports
Figure 9: Pharmaceutical Market, Brazil, Top Export Partners
Figure 10: Pharmaceutical Market, Brazil, Pharmaceutical Imports
Figure 11: Pharmaceutical Market, Brazil, Top Import Partners
Figure 12: Pharmaceutical Supply Channels, Brazil
Figure 13: Generic Drugs Market, Brazil($B), 2010-2018
Figure 14: OTC Product Group Sales ($M), Brazil, 2013-2016
Figure 15: Top Five Therapeutic Areas based on Mortality by Major Disease Areas (thousand), Brazil, 2016
Figure 16: Pharmaceutical Market, Major Players, Brazil
Figure 17: Medical Device Market, Brazil, Revenue Forecast ($B), 2021-2025
Figure 18: Medical Device Market, Brazil, Revenue by Segment ($B), 2018
Figure 19: General Surgery Devices Market, Brazil, Revenue ($B), 2015-2022
Figure 20: General Surgery Devices Market, Brazil, Market Share of Major Players (%), 2018
Figure 21:Diagnostic Imaging Market, Brazil, Revenue ($B), 2015-2022
Figure 22:Diagnostic Imaging Market, Brazil, Market Share of Major Players (%), 2015
Figure 23:IVD Market, Brazil, Revenue ($B), 2015-2022
Figure 24:IVD Market, Brazil, Market Share of Major Players (%), 2017
Figure 25: Ophthalmic Devices Market, Brazil, Revenue ($B), 2015-2022
Figure 26: Ophthalmic Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2015
Figure 27: Orthopedic Devices Market, Brazil, Revenue ($M), 2015-2022
Figure 28: Orthopedic Devices Market, Brazil, Revenue ($M) and Market Share (%) of Major Companies, 2018
Figure 29: Diagnostic Market, Brazil, Revenue ($B), 2015-2018
Figure 30: Diagnostic Market, Brazil, Revenue Forecast ($B), 2019-2022
Figure 31: Medical Device Market - Major Players
Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Brazil, 2018-2019
Figure 33: Deal Value and Deal Count, by Quarter, Pharmaceutical Market, Brazil, 2018-2019
Figure 34: Deal Value and Deal Count, by Subtype, Pharmaceutical Market, Brazil, 2018-2019
Figure 35: Top Three Therapy Areas by Deal Value, Pharmaceutical Market, Brazil, 2018-2019
Figure 36:Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Brazil, 2018-2019
Figure 37: M&A Deals by Therapy Area by Value and Number, Pharmaceutical Market, Brazil, 2018-2019
Figure 38: Medical Device Market Deals by Deal Value ($M), Brazil, 2018
Figure 39: Medical Device Market Deals, Brazil, Top Therapy Area by Deal Value and Deal Count, 2018
Figure 40: Ministry of Health, Structure, Brazil, 2018
Figure 41: Departments of Ministry of Health Structure, Brazil, 2018
Figure 42: Reimbursement Process, Brazil, 2018
Figure 43: Roles and Responsibilities of ANS
Figure 44: Responsibilities of CONSU
Figure 45: OOP Expenditure (% of total expenditure on health)
Figure 46: Annual Rate of Change (%), Consumer Price Index
Figure 47: Categorization of Drugs, Brazil
Figure 48: Pricing Policies, Brazil
Figure 49: ANVISA: Organization Structure and Responsibilities
Figure 50: ANVISA Organogram
Figure 51: Drug Approval Process, 2016
Figure 52: Regulatory Pathways for Dossier Registration, Brazil
Figure 53: Biologics Approved in Brazil
Figure 54: Regulatory Pathway for Registration of Biological Products by ANVISA
Figure 55: Medical Device Approval Process, Brazil, 2019
Figure 56: Medical Device Approval Timeframe and Fees, Brazil, 2019
Figure 57: Medical Device Approval Process, Brazil, 2019
Figure 58: Requirements of Patent Application, Brazil
Figure 59: Details to Be Submitted for Request of Examination
Figure 60: Trademark Requirements to Be Submitted in INPI
Figure 61: Clinical Trial Regulation, Brazil, 2018
Figure 62: OTC Advertising Acts Related to Prohibition, Brazil, 2018
Figure 63: Documents to Be Submitted to ANVISA for Setting Up the Pharmacy, Brazil, 2018
Figure 64: Circumstances Requiring Change in Pharmacy Permit, Brazil, 2018
Figure 65: Packaging Requirements, Brazil, 2018
Figure 66: Number of Hospitals, Brazil, 2010-2018
Figure 67: Number of ASCs, Brazil, 2010-2018
Figure 68: Hospital Beds (per million population), Brazil, 2010-2018
Figure 69: Diagnostic Equipment (per million population), Brazil, 2008-2016
Figure 70: Life Expectancy, Brazil, 2010-2016
Figure 71: Immunization Rate (%), Brazil, 2010-2017
Figure 72: PM2.5 (μg/m3), Brazil, 2010-2016
Figure 73: CO2 Emissions (mt), Brazil, 2010-2016
Figure 74: Physicians (per 1,000 population), Brazil, 2009-2018
Figure 75: Nurses (per 1,000 population), Brazil, 2010-2018
Figure 76: Major Causes of Mortality (number of deaths), Brazil, 2016
Figure 77: Major Causes of Male Mortality, No. of Deaths (‘000), Brazil, 2016
Figure 78: Major Causes of Female Mortality, No. of Deaths (‘000), Brazil, 2016
Figure 79: Disability-Adjusted Life Years by Major Disease (‘000), Brazil, 2016
Figure 80: Healthcare Expenditure as Percentage of GDP (%), Brazil, 2009-2017
Figure 81: Public-Private Share (%), Brazil, 2009-2015
Summary
GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil",. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Brazil. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Brazil. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Brazil, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, GSK, Pfizer, Novartis and Hypera) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Roche, B Braun and Hologic)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Brazil
- Porter’s five forces analysis for pharmaceutical and medical devices market of Brazil
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Brazilian healthcare market.
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Italian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Brazilian healthcare market.
Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Tables
Table 1: Top Five Therapeutic Areas based on Mortality by Major Disease Areas (thousand), Brazil, 2016
Table 2: Medical Device Market, Brazil, Revenue by Segment ($B), 2018
Table 3: General Surgery Devices Market, Brazil, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 4: Diagnostic Imaging Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2015
Table 5: IVD Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2017
Table 6:Ophthalmic Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2015
Table 7: Orthopedic Devices Market, Brazil, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 8: Patent Fees, Brazil, 2017
Table 9: Trademarks Fees ($), Brazil, 2014
List of Figures
Figure 1: Pharmaceutical Market, Brazil, Revenue ($B), 2015-2020
Figure 2: Medical Device Market, Brazil, Revenue ($B), 2015-2020
Figure 3: Number of Deals (2018-2019)
Figure 4: 2018-19 Deal Overview By Region
Figure 5: Country Profile, Brazil, 2018
Figure 6: Pharmaceutical Market, Brazil, Revenue ($B), 2010-2018
Figure 7: Pharmaceutical Market, Brazil, Revenue Forecast ($B), 2019-2022
Figure 8: Pharmaceutical Market, Brazil, Pharmaceutical Exports
Figure 9: Pharmaceutical Market, Brazil, Top Export Partners
Figure 10: Pharmaceutical Market, Brazil, Pharmaceutical Imports
Figure 11: Pharmaceutical Market, Brazil, Top Import Partners
Figure 12: Pharmaceutical Supply Channels, Brazil
Figure 13: Generic Drugs Market, Brazil($B), 2010-2018
Figure 14: OTC Product Group Sales ($M), Brazil, 2013-2016
Figure 15: Top Five Therapeutic Areas based on Mortality by Major Disease Areas (thousand), Brazil, 2016
Figure 16: Pharmaceutical Market, Major Players, Brazil
Figure 17: Medical Device Market, Brazil, Revenue Forecast ($B), 2021-2025
Figure 18: Medical Device Market, Brazil, Revenue by Segment ($B), 2018
Figure 19: General Surgery Devices Market, Brazil, Revenue ($B), 2015-2022
Figure 20: General Surgery Devices Market, Brazil, Market Share of Major Players (%), 2018
Figure 21:Diagnostic Imaging Market, Brazil, Revenue ($B), 2015-2022
Figure 22:Diagnostic Imaging Market, Brazil, Market Share of Major Players (%), 2015
Figure 23:IVD Market, Brazil, Revenue ($B), 2015-2022
Figure 24:IVD Market, Brazil, Market Share of Major Players (%), 2017
Figure 25: Ophthalmic Devices Market, Brazil, Revenue ($B), 2015-2022
Figure 26: Ophthalmic Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2015
Figure 27: Orthopedic Devices Market, Brazil, Revenue ($M), 2015-2022
Figure 28: Orthopedic Devices Market, Brazil, Revenue ($M) and Market Share (%) of Major Companies, 2018
Figure 29: Diagnostic Market, Brazil, Revenue ($B), 2015-2018
Figure 30: Diagnostic Market, Brazil, Revenue Forecast ($B), 2019-2022
Figure 31: Medical Device Market - Major Players
Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Brazil, 2018-2019
Figure 33: Deal Value and Deal Count, by Quarter, Pharmaceutical Market, Brazil, 2018-2019
Figure 34: Deal Value and Deal Count, by Subtype, Pharmaceutical Market, Brazil, 2018-2019
Figure 35: Top Three Therapy Areas by Deal Value, Pharmaceutical Market, Brazil, 2018-2019
Figure 36:Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Brazil, 2018-2019
Figure 37: M&A Deals by Therapy Area by Value and Number, Pharmaceutical Market, Brazil, 2018-2019
Figure 38: Medical Device Market Deals by Deal Value ($M), Brazil, 2018
Figure 39: Medical Device Market Deals, Brazil, Top Therapy Area by Deal Value and Deal Count, 2018
Figure 40: Ministry of Health, Structure, Brazil, 2018
Figure 41: Departments of Ministry of Health Structure, Brazil, 2018
Figure 42: Reimbursement Process, Brazil, 2018
Figure 43: Roles and Responsibilities of ANS
Figure 44: Responsibilities of CONSU
Figure 45: OOP Expenditure (% of total expenditure on health)
Figure 46: Annual Rate of Change (%), Consumer Price Index
Figure 47: Categorization of Drugs, Brazil
Figure 48: Pricing Policies, Brazil
Figure 49: ANVISA: Organization Structure and Responsibilities
Figure 50: ANVISA Organogram
Figure 51: Drug Approval Process, 2016
Figure 52: Regulatory Pathways for Dossier Registration, Brazil
Figure 53: Biologics Approved in Brazil
Figure 54: Regulatory Pathway for Registration of Biological Products by ANVISA
Figure 55: Medical Device Approval Process, Brazil, 2019
Figure 56: Medical Device Approval Timeframe and Fees, Brazil, 2019
Figure 57: Medical Device Approval Process, Brazil, 2019
Figure 58: Requirements of Patent Application, Brazil
Figure 59: Details to Be Submitted for Request of Examination
Figure 60: Trademark Requirements to Be Submitted in INPI
Figure 61: Clinical Trial Regulation, Brazil, 2018
Figure 62: OTC Advertising Acts Related to Prohibition, Brazil, 2018
Figure 63: Documents to Be Submitted to ANVISA for Setting Up the Pharmacy, Brazil, 2018
Figure 64: Circumstances Requiring Change in Pharmacy Permit, Brazil, 2018
Figure 65: Packaging Requirements, Brazil, 2018
Figure 66: Number of Hospitals, Brazil, 2010-2018
Figure 67: Number of ASCs, Brazil, 2010-2018
Figure 68: Hospital Beds (per million population), Brazil, 2010-2018
Figure 69: Diagnostic Equipment (per million population), Brazil, 2008-2016
Figure 70: Life Expectancy, Brazil, 2010-2016
Figure 71: Immunization Rate (%), Brazil, 2010-2017
Figure 72: PM2.5 (μg/m3), Brazil, 2010-2016
Figure 73: CO2 Emissions (mt), Brazil, 2010-2016
Figure 74: Physicians (per 1,000 population), Brazil, 2009-2018
Figure 75: Nurses (per 1,000 population), Brazil, 2010-2018
Figure 76: Major Causes of Mortality (number of deaths), Brazil, 2016
Figure 77: Major Causes of Male Mortality, No. of Deaths (‘000), Brazil, 2016
Figure 78: Major Causes of Female Mortality, No. of Deaths (‘000), Brazil, 2016
Figure 79: Disability-Adjusted Life Years by Major Disease (‘000), Brazil, 2016
Figure 80: Healthcare Expenditure as Percentage of GDP (%), Brazil, 2009-2017
Figure 81: Public-Private Share (%), Brazil, 2009-2015
Related Report
